ICM
GPN icon

Invenomic Capital Management’s Global Payments GPN Stock Holding History

Invenomic Capital Management’s Portfolio GPN Stock Details GPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$64M Sell
881,579
-32,926
-4% -$2.27M 3.82% 1
2026
Q1 		$61.5M Buy
914,505
+117,009
+15% +$8.63M 2.82% 3
2025
Q4 		$61.7M Buy
797,496
+116,402
+17% +$9.37M 2.87% 2
2025
Q3 		$56.6M Buy
681,094
+68,071
+11% +$5.73M 2.74% 2
2025
Q2 		$49.1M Buy
613,023
+109,057
+22% +$8.63M 2.79% 1
2025
Q1 		$49.3M Sell
503,966
-31,488
-6% -$3.29M 2.49% 3
2024
Q4 		$60M Sell
535,454
-146,803
-22% -$16.1M 2.86% 3
2024
Q3 		$69.9M Buy
682,257
+205,851
+43% +$21.4M 3.84% 1
2024
Q2 		$46.1M Buy
476,406
+268,780
+129% +$29.6M 2.24% 4
2024
Q1 		$27.8M Buy
207,626
+61,801
+42% +$8.17M 1.48% 19
2023
Q4 		$18.5M Sell
145,825
-105,746
-42% -$12.2M 0.84% 37
2023
Q3 		$29M Buy
251,571
+6,679
+3% +$795K 1.22% 24
2023
Q2 		$24.1M Buy
244,892
+43,022
+21% +$4.42M 1.22% 25
2023
Q1 		$21.2M Buy
+201,870
New +$21.9M 1.2% 30

Other funds holding GPN

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invenomic Capital Management's GPN Position: Q2 2026 in Review

Invenomic Capital Management reduced its Global Payments (GPN) stake by 3.6% in Q2 2026, selling an estimated $2.27M and leaving 881,579 shares worth $64M. The position accounts for 3.82% of the portfolio, ranked #1.

Invenomic Capital Management first reported a position in GPN in Q1 2023 and has held it in 14 quarters since. The position peaked at $69.9M in Q3 2024. 794 funds tracked by Wall St. Rank hold GPN as of Q2 2026.

  • Invenomic Capital Management held 881,579 shares of Global Payments worth $64M as of Q2 2026.
  • Invenomic Capital Management sold 32,926 Global Payments shares in Q2 2026, an estimated $2.27M.
  • Global Payments made up 3.82% of Invenomic Capital Management's portfolio in Q2 2026, its #1 holding.
  • Invenomic Capital Management first reported a position in Global Payments in Q1 2023 and has held it in 14 quarters since.
  • Invenomic Capital Management's Global Payments position peaked at $69.9M in Q3 2024.
  • 794 funds tracked by Wall St. Rank held Global Payments as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.